{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T06:31:43Z","timestamp":1696401103303},"reference-count":32,"publisher":"Japan Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1507\/endocrj.k11e-026","type":"journal-article","created":{"date-parts":[[2011,4,27]],"date-time":"2011-04-27T05:20:18Z","timestamp":1303881618000},"page":"527-534","source":"Crossref","is-referenced-by-count":7,"title":["Clinicopathological features, biochemical and molecular markers in 5 patients with adrenocortical carcinoma"],"prefix":"10.1507","volume":"58","author":[{"given":"Ryuji","family":"Kouyama","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiichiro","family":"Hiraishi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Izumiyama","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Akashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kihara","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Homma","sequence":"additional","affiliation":[{"name":"Central Clinical Laboratories, Keio University Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Keio University, School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1007\/s003450050101"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.2.637"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0031"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2008.10.008"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Libe R, Fratticci A, Bertherat J (2007) Adrenocortical cancer: pathophysiology and clinical management. <i>Endocr Relat Cancer<\/i> 14: 13-28.","DOI":"10.1677\/erc.1.01130"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Weiss LM (1984) Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. <i>Am J Surg Path<\/i> 8: 163-169.","DOI":"10.1097\/00000478-198403000-00001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Arola J, Salmenkivi K, Liu J, Kahri AI, Heikkila P (2000) p53 and Ki67 in adrenocortical tumors. <i>Endocr Res<\/i> 26: 861-865.","DOI":"10.3109\/07435800009048609"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kikuchi E, Yanaihara H, Nakashima J, Homma K, Ohigashi T, Asakura H, Tachibana M, Shibata H, Saruta T, Murai M (2000) Urinary steroid profile in adrenocortical tumors. <i>Biomed Pharmacother<\/i> 54 (Suppl 1): 194s-197s.","DOI":"10.1016\/S0753-3322(00)80043-8"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.50.783"},{"key":"10","unstructured":"10. Sasano H, Miyazaki S, Sawai T, Sasano N, Nagura H, Funahashi H, Aiba M, Demura H (1992) Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases. <i>Mod Pathol<\/i> 5: 23-29."},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.53.237"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(93)90088-X"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS (2003) Management of the clinically inapparent adrenal mass (&ldquo;incidentaloma&bdquo;). <i>Ann Intern Med<\/i> 138: 424-429.","DOI":"10.7326\/0003-4819-138-5-200303040-00013"},{"key":"14","unstructured":"14. Lau J, Balk E, Rothberg M, Ioannidis JP, DeVine D, Chew P, Kupelnick B, Miller K (2002) Management of clinically inapparent adrenal mass. <i>Evid Rep Technol Assess<\/i> (Summ) 56: 1-5."},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2006.02505.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Stojadinovic A, Brennan MF, Hoos A, Omeroglu A, Leung DH, Dudas ME, Nissan A, Cordon-Cardo C, Ghossein RA (2003) Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis. <i>Mod Pathol<\/i> 16: 742-751.","DOI":"10.1097\/01.MP.0000081730.72305.81"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-006-0006-0"},{"key":"18","unstructured":"18. Gr&ouml;ndal S, Eriksson B, Hagen&auml;s L, Werner S, Curstedt T (1990) Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma. <i>Acta Endocrinol<\/i> (Copenh)122: 656-663."},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2730"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1385\/EP:12:4:429"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gicquel C, Raffin-Sanson ML, Gaston V, Bertagna X, Plouin PF, Schlumberger M, Louvel A, Luton JP, Le Bouc Y (1997) Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. <i>J Clin Endocrinol Metab<\/i>82: 2559-2565.","DOI":"10.1210\/jc.82.8.2559"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.6.1444"},{"key":"23","unstructured":"23. Boulle N, Logi&eacute; A, Gicquel C, Perin L, Le Bouc Y (1998) Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors. <i>J Clin Endocrinol Metab<\/i> 83: 1713-1720."},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.3.852"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Soon PS, Gill AJ, Benn DE, Clarkson A, Robinson BG, McDonald KL, Sidhu SB (2009) Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. <i>Endocr Relat Cancer<\/i>16: 573-583.","DOI":"10.1677\/ERC-08-0237"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Logie A, Boulle N, Gaston V, Perin L, Boudou P, Le Bouc Y, Gicquel C (1999) Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line. <i>J Mol Endocrinol<\/i> 23: 23-32.","DOI":"10.1677\/jme.0.0230023"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-814563"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Soon PS, McDonald KL, Robinson BG, Sidhu SB (2008) Molecular markers and the pathogenesis of adrenocortical cancer. <i>Oncologist<\/i>13: 548-561.","DOI":"10.1634\/theoncologist.2007-0243"},{"issue":"18","key":"29","first-page":"6762","volume":"61","author":"GICQUEL C","year":"2001","ISSN":"http:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Boulle N, Baudin E, Gicquel C, Logi&eacute; A, Bertherat J, Penfornis A, Bertagna X, Luton JP, Schlumberger M, Le Bouc Y (2001) Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors. <i>Eur J Endocrinol<\/i> 144: 29-36.","DOI":"10.1530\/eje.0.1440029"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1075"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ikushima H, Miyazono K (2010) TGFbeta signalling: a complex web in cancer progression. <i>Nat Rev Cancer<\/i> 10: 415-424.","DOI":"10.1038\/nrc2853"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/7\/58_K11E-026\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:56:03Z","timestamp":1618296963000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/7\/58_K11E-026\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k11e-026","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}